Congratulations to Virginia Weis, University Distinguished Professor of Integrative Biology, for receiving the Eminence in Research Award from the International Coral Reef Society.
Mathematics and statistics are two of the quickest-growing fields in the country, and it's not hard to guess why. In part three of this series, we examine some of the data-driven research that is helping usher in a new era of climate policy and action.
For many OSU materials scientists, fighting climate change means finding cleaner energy sources, developing sustainable alternatives to wasteful industry processes, and drawing on unconventional means to reduce the pollution already in the environment.
University Distinguished Professor of Biochemistry and Biophysics Michael Freitag will present the College of Science 2022 F.A. Gilfillan Memorial Lecture on May 3.
Bartholomew’s glasswork that fuses artistry with research is on exhibition in The Little Gallery in Kidder Hall from March 7 to April 8, 2022. A new fellowship invites scientist-artists to explore interdisciplinary projects.
Seed funding from the College of Science Research and Innovation Seed (SciRIS) program continues to bolster ambitious and expansive research projects across biomedical science, fluid dynamics, quantum mechanics and more.
The College of Science is pleased to congratulate David Hendrix, associate professor of biochemistry and biophysics, on his recent award of 638K from the United States Department of Agriculture National Institute of Food and Agriculture.
The College of Science gathered yesterday on February 22 to recognize academic and teaching excellence of our esteemed faculty and staff at the College's 2021-22 Combined Awards Ceremony. The first half of the ceremony celebrated exceptional research and administration.
Biochemistry and biophysics researchers have made a key advance against dangerous and costly surgical site infections, the type of infection most commonly associated with health care procedures.
Researchers from the Department of Biochemistry and Biophysics have discovered a new class of potential drug targets for people suffering from neurodegenerative conditions such as Alzheimer’s, Parkinson’s and Lou Gehrig’s disease.
